Neurotrope Inc $ 0.94 0 (0%)
Volume:
0
Avg Vol (1m):
320,567
Market Cap $:
22.41 Mil
Enterprise Value $:
-4,590,000.00
P/E (TTM):
0.00
P/B:
0.80
Financial Strength | 7/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
Cash-To-Debt | No Debt | ||
Interest Coverage | No Debt | ||
Piotroski F-Score | 3 | ||
WACC vs ROIC |
Profitability Rank | 1/10 |
Current | Vs Industry | Vs History | |
---|---|---|---|
ROE % | -48.88 | ||
ROA % | -47.39 | ||
ROC (Joel Greenblatt) % | -16489.39 | ||
3-Year EBITDA Growth Rate | 40.5 | ||
3-Year EPS without NRI Growth Rate | 41.1 |
NTRP
Valuation Rank |
Current | Vs Industry | Vs History | |
---|---|---|---|
PB Ratio | 0.8 | ||
EV-to-EBIT | 0.42 | ||
EV-to-EBITDA | 0.42 | ||
Current Ratio | 22.4 | ||
Quick Ratio | 22.4 |
Dividend & Buy Back |
Current | Vs Industry | Vs History | |
---|---|---|---|
3-Year Average Share Buyback Ratio | -24.6 |
Valuation & Return |
Current | Vs Industry | Vs History | |
---|---|---|---|
Price-to-Tangible-Book | 0.8 | ||
Earnings Yield (Greenblatt) % | 238.1 |